Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Boultwood, J, Perry, J, Pellagatti, A, Fernandez-Mercado, M, Fernandez-Santamaria, C, Calasanz, M, Larrayoz, M, Garcia-Delgado, M, Giagounidis, A, Malcovati, L, Della Porta, MG, Jädersten, M, Killick, S, Hellström-Lindberg, E, Cazzola, M, Wainscoat, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2009)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2010)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2011)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2008)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2007)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2013)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2008)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2005)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2007)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2014)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
de réir: Wang, L, et al.
Foilsithe / Cruthaithe: (2007)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2014)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2008)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2013)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
de réir: Jadersten, M, et al.
Foilsithe / Cruthaithe: (2005)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
de réir: Davies, C, et al.
Foilsithe / Cruthaithe: (2013)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.
de réir: Davies, C, et al.
Foilsithe / Cruthaithe: (2013)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2017)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
de réir: Esoof, N, et al.
Foilsithe / Cruthaithe: (2006)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2013)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
de réir: Jacqueline Boultwood, et al.
Foilsithe / Cruthaithe: (2008-04-01)

Gene expression profiling in the myelodysplastic syndromes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2005)

Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
de réir: Wang, L, et al.
Foilsithe / Cruthaithe: (2008)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2004)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
de réir: Marta Fernandez-Mercado, et al.
Foilsithe / Cruthaithe: (2013-12-01)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
de réir: Pellagati, A, et al.
Foilsithe / Cruthaithe: (2008)

Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment
de réir: Scharenberg, C, et al.
Foilsithe / Cruthaithe: (2011)